Dec 05, 2022 / 03:40PM GMT
Joanna Sylvia Gajuk - BofA Securities, Research Division - VP
This is Joanna Gajuk. I'm the healthcare equity analyst at Bank of America. I cover home health and other home care companies, and it's my pleasure now to host this session with Chemed, the largest hospice provider that also owns a plumbing company, Roto-Rooter, and today with us, I guess, only joining us with audio is Kevin McNamara, President and CEO; and also Dave Williams, the CFO; as well as Nick Westfall, CEO of Vitas. And I'll just comment to the audience before we start, because the gentlemen-- we go right into Q&A.
Questions and Answers:
Joanna Sylvia Gajuk - BofA Securities, Research Division - VPSo welcome, everyone, again. I guess I'll just start with questions here. So first, I guess on margins. So the Vitas margins have been coming in better than expected actually this year, and the company raised guidance for margins with the third quarter results. So maybe first, can you kind of walk us through what's been driving the upside of the margins, and is that sustainable going